Literature DB >> 3048531

Femorodistal vein bypass graft stenoses.

M J Grigg1, A N Nicolaides, J H Wolfe.   

Abstract

Eighty femorodistal in situ vein bypass grafts have been evaluated at 3-monthly intervals clinically, with ankle:brachial pressure indices (ABI), by intravenous digital subtraction angiography (IV DSA) and by Duplex scanning. Five grafts (6 per cent) failed in the perioperative period. Nineteen (25 per cent) of the remaining 75 grafts subsequently developed stenoses on IV DSA during the first 12 months. All angiographic stenoses were detected by Duplex scanning using velocity ratio criteria before the development of symptoms or a measurable decline in ABI, i.e. while non-haemodynamically significant. This technique involves scanning the entire length of the graft but allows even minor stenoses to be detected and progression of stenoses can be determined. At a mean follow-up of 12 months (3-18 months), four (7 per cent) of the fifty-six grafts without stenoses occluded. Eight (42 per cent) of the nineteen stenosed grafts either occluded or developed symptoms. None of the occluded grafts in this series could be salvaged. Non-haemodynamically significant vein stenoses can be detected non-invasively, occur frequently and are associated with graft failure.

Entities:  

Mesh:

Year:  1988        PMID: 3048531     DOI: 10.1002/bjs.1800750806

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

Review 1.  Vein quality in infrainguinal revascularisation: assessment by angioscopy and histology.

Authors:  Y G Wilson
Journal:  Ann R Coll Surg Engl       Date:  1998-01       Impact factor: 1.891

2.  Vein graft surveillance: is the case proven?

Authors:  D K Beattie; R M Greenhalgh; A H Davies
Journal:  Ann R Coll Surg Engl       Date:  1997-01       Impact factor: 1.891

3.  An aggressive policy of bilateral saphenous vein harvest for infragenicular revascularisation in the era of multidrug resistant bacteria.

Authors:  G J Murphy; D Kipgen; M J S Dennis; R D Sayers
Journal:  Postgrad Med J       Date:  2002-06       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.